AAAAAA

   
Results: 1-25 |
Results: 25

Authors: Eichelbaum, M Evans, W Yamazoe, Y
Citation: M. Eichelbaum et al., A tribute to Frank Gonzalez, PHARMACOGEN, 11(5), 2001, pp. 371-371

Authors: Matsumoto, S Yamazoe, Y
Citation: S. Matsumoto et Y. Yamazoe, Involvement of multiple human cytochromes P450 in the liver microsomal metabolism of astemizole and a comparison with terfenadine, BR J CL PH, 51(2), 2001, pp. 133-142

Authors: Homan, W Kamiyama, Y Yoshinari, K Sasano, H Shimada, M Nagata, K Yamazoe, Y
Citation: W. Homan et al., Enzymatic characterization and interspecies difference of phenol sulfotransferases, ST1A forms, DRUG META D, 29(3), 2001, pp. 274-281

Authors: Miyata, M Furukawa, M Takahashi, K Gonzalez, FJ Yamazoe, Y
Citation: M. Miyata et al., Mechanism of 7,12-dimethylbenz[alpha]anthracene-induced immunotoxicity: Role of metabolic activation at the target organ, JPN J PHARM, 86(3), 2001, pp. 302-309

Authors: Guo, LQ Taniguchi, M Chen, QY Baba, K Yamazoe, Y
Citation: Lq. Guo et al., Inhibitory potential of herbal medicines on human cytochrome P450-mediatedoxidation: Properties of Umbelliferous or Citrus crude drugs and their relative prescriptions, JPN J PHARM, 85(4), 2001, pp. 399-408

Authors: Fukuda, K Guo, LQ Ohashi, N Yoshikawa, M Yamazoe, Y
Citation: K. Fukuda et al., Amounts and variation in grapefruit juice of the main components causing grapefruit-drug interaction, J CHROMAT B, 741(2), 2000, pp. 195-203

Authors: Sasaki, S Yamazoe, Y Maeda, H
Citation: S. Sasaki et al., Effect of chain hydrophobicity on volume change behavior of ionic gels in binding of hydrophobic counterions, LANGMUIR, 16(18), 2000, pp. 7126-7130

Authors: Nagata, K Yamazoe, Y
Citation: K. Nagata et Y. Yamazoe, Pharmacogenetics of sulfotransferase, ANN R PHARM, 40, 2000, pp. 159-176

Authors: Kato, R Yamazoe, Y
Citation: R. Kato et Y. Yamazoe, History of drug metabolism research in Japan, DRUG METAB, 32(1), 2000, pp. 45-79

Authors: Tassaneeyakul, W Tassaneeyakul, W Vannaprasaht, S Yamazoe, Y
Citation: W. Tassaneeyakul et al., Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice, BR J CL PH, 49(2), 2000, pp. 139-144

Authors: Guo, LQ Fukuda, K Ohta, T Yamazoe, Y
Citation: Lq. Guo et al., Role of furanocoumarin derivatives on grapefruit juice-mediated inhibitionof human CYP3A activity, DRUG META D, 28(7), 2000, pp. 766-771

Authors: Hojo, I Hanioka, K Miyata, M Yamazoe, Y
Citation: I. Hojo et al., Hepatotoxicity of acetaminophen and N-acetyl-p-benzoquinone imine and enhancement by fructose, XENOBIOTICA, 30(9), 2000, pp. 933-941

Authors: Nakamura, T Okada, K Nagata, K Yamazoe, Y
Citation: T. Nakamura et al., Intestinal cytochrome P450 and response to rifampicin in rabbits, JPN J PHARM, 82(3), 2000, pp. 232-239

Authors: Guo, LQ Taniguchi, M Xiao, YQ Baba, K Ohta, T Yamazoe, Y
Citation: Lq. Guo et al., Inhibitory effect of natural furanocoumarins on human microsomal cytochrome P450 3A activity, JPN J PHARM, 82(2), 2000, pp. 122-129

Authors: Tassaneeyakul, W Guo, LQ Fukuda, K Ohta, T Yamazoe, Y
Citation: W. Tassaneeyakul et al., Inhibition selectivity of grapefruit juice components on human cytochromesP450, ARCH BIOCH, 378(2), 2000, pp. 356-363

Authors: Fujita, K Nagata, K Yamazaki, T Watanabe, E Shimada, M Yamazoe, Y
Citation: K. Fujita et al., Enzymatic characterization of human cytosolic sulfotransferases; Identification of ST1B2 as a thyroid hormone sulfotransferase, BIOL PHAR B, 22(5), 1999, pp. 446-452

Authors: Yamazoe, Y Nagata, K Yoshinari, K Fujita, K Shiraga, T Iwasaki, K
Citation: Y. Yamazoe et al., Sulfotransferase catalyzing sulfation of heterocyclic amines, CANCER LETT, 143(2), 1999, pp. 103-107

Authors: Shiraga, T Hata, T Yamazoe, Y Ohno, Y Iwasaki, K
Citation: T. Shiraga et al., N-sulphoconjugation of amines by human cytosolic hydroxysteroid sulphotransferase, XENOBIOTICA, 29(4), 1999, pp. 341-347

Authors: Shimada, M Watanabe, E Iida, Y Nagata, K Yamazoe, Y
Citation: M. Shimada et al., Alteration of hepatic sulfation by endotoxin, JPN J PHARM, 80(4), 1999, pp. 371-373

Authors: Fujita, K Nagata, K Watanabe, E Shimada, M Yamazoe, Y
Citation: K. Fujita et al., Bacterial expression and functional characterization of a rat thyroid hormone sulfotransferase, ST1B1, JPN J PHARM, 79(4), 1999, pp. 467-475

Authors: Taniguchi, M Xiao, YQ Liu, XH Yabu, A Hada, Y Guo, LQ Yamazoe, Y Baba, K
Citation: M. Taniguchi et al., Rivulobirin E and rivulotririn C from Pleurospermum rivulorum, CHEM PHARM, 47(5), 1999, pp. 713-715

Authors: Yasumori, T Chen, LS Li, QH Ueda, M Tsuzuki, T Goldstein, JA Kato, R Yamazoe, Y
Citation: T. Yasumori et al., Human CYP2C-mediated stereoselective phenytoin hydroxylation in Japanese: Difference in chiral preference of CYP2C9 and CYP2C19, BIOCH PHARM, 57(11), 1999, pp. 1297-1303

Authors: Nagata, K Ogino, M Shimada, M Miyata, M Gonzalez, FJ Yamazoe, Y
Citation: K. Nagata et al., Structure and expression of the rat CYP3A1 gene: Isolation of the gene (P450/6 beta B) and characterization of the recombinant protein, ARCH BIOCH, 362(2), 1999, pp. 242-253

Authors: Shiraga, T Iwasaki, K Hata, T Yoshinari, K Nagata, K Yamazoe, Y Ohno, Y
Citation: T. Shiraga et al., Purification and characterization of two amine N-sulfotransferases, AST-RB1 (ST3A1) and AST-RB2 (ST2A8), from liver cytosols of male rabbits, ARCH BIOCH, 362(2), 1999, pp. 265-274

Authors: Ogino, M Nagata, K Miyata, M Yamazoe, Y
Citation: M. Ogino et al., Hepatocyte nuclear factor 4-mediated activation of rat CYP3A1 gene and itsmodes of modulation by apolipoprotein AI regulatory protein I and v-ErbA-related protein 3, ARCH BIOCH, 362(1), 1999, pp. 32-37
Risultati: 1-25 |